{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:47:07Z","timestamp":1793155627618,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003852","name":"Regione Campania","doi-asserted-by":"publisher","award":["Quota vincolata per la prevenzione e cura della Fibrosi Cistica L. 548\/94, Ricerca. FSN 2015, 2016, 2017 and 2018"],"award-info":[{"award-number":["Quota vincolata per la prevenzione e cura della Fibrosi Cistica L. 548\/94, Ricerca. FSN 2015, 2016, 2017 and 2018"]}],"id":[{"id":"10.13039\/501100003852","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-84191-9","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T22:44:45Z","timestamp":1735857885000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Metabolomic profiling of saliva from cystic fibrosis patients"],"prefix":"10.1038","volume":"15","author":[{"given":"M.","family":"Caterino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Costanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Castaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Iacotucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Carnovale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ruoppolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gelzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Castaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"84191_CR1","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","volume":"388","author":"JS Elborn","year":"2016","unstructured":"Elborn, J. S. Cystic fibrosis. Lancet 388, 2519\u20132531 (2016).","journal-title":"Lancet"},{"key":"84191_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13052-019-0647-5","volume":"45","author":"E Lombardi","year":"2019","unstructured":"Lombardi, E., Gambazza, S., Pradal, U. & Braggion, C. Lung clearance index in subjects with cystic fibrosis in Italy. Ital. J. Pediatr. 45, 56 (2019).","journal-title":"Ital. J. Pediatr."},{"key":"84191_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","volume":"8","author":"SC Bell","year":"2020","unstructured":"Bell, S. C. et al. The future of cystic fibrosis care: a global perspective. Lancet Respir. Med. 8, 65\u2013124 (2020).","journal-title":"Lancet Respir. Med."},{"key":"84191_CR4","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1164\/rccm.200303-434OC","volume":"168","author":"PM Farrell","year":"2003","unstructured":"Farrell, P. M. et al. Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis. Am. J. Respir Crit. Care Med. 168, 1100\u20131108 (2003).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"84191_CR5","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3390\/diagnostics10040222","volume":"10","author":"A Castaldo","year":"2020","unstructured":"Castaldo, A. et al. Salivary cytokines and airways disease severity in patients with cystic fibrosis. Diagnostics (Basel) 10, 222 (2020).","journal-title":"Diagnostics (Basel)"},{"key":"84191_CR6","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3390\/diagnostics10110915","volume":"10","author":"M Gelzo","year":"2020","unstructured":"Gelzo, M. et al. Impaired ratio of unsaturated to saturated non-esterified fatty acids in saliva from patients with cystic fibrosis. Diagnostics (Basel) 10, 915 (2020).","journal-title":"Diagnostics (Basel)"},{"key":"84191_CR7","doi-asserted-by":"publisher","first-page":"5838","DOI":"10.1038\/s41598-022-09618-7","volume":"12","author":"V Carnovale","year":"2022","unstructured":"Carnovale, V. et al. Oxylipin profile in saliva from patients with cystic fibrosis reveals a balance between pro-resolving and pro-inflammatory molecules. Sci. Rep. 12, 5838 (2022).","journal-title":"Sci. Rep."},{"key":"84191_CR8","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41598-022-24429-6","volume":"13","author":"M Caterino","year":"2023","unstructured":"Caterino, M. et al. Lipidomic alterations in human saliva from cystic fibrosis patients. Sci. Rep. 13, 600 (2023).","journal-title":"Sci. Rep."},{"key":"84191_CR9","doi-asserted-by":"crossref","unstructured":"Agatonovic-Kustrin, S. et al. Analytical strategies in lipidomics for discovery of functional biomarkers from human saliva. Dis. Mark. 6741518 (2019).","DOI":"10.1155\/2019\/6741518"},{"key":"84191_CR10","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.envint.2008.09.003","volume":"35","author":"M Esteban","year":"2009","unstructured":"Esteban, M. & Casta\u00f1o, A. Non-invasive matrices in human biomonitoring: a review. Environ. Int. 35, 438\u2013449 (2009).","journal-title":"Environ. Int."},{"key":"84191_CR11","doi-asserted-by":"publisher","first-page":"25270","DOI":"10.1038\/srep25270","volume":"6","author":"V Capobianco","year":"2016","unstructured":"Capobianco, V. et al. Proteome analysis of human amniotic mesenchymal stem cells (hA-MSCs) reveals impaired antioxidant ability, cytoskeleton and metabolic functionality in maternal obesity. Sci. Rep. 6, 25270 (2016).","journal-title":"Sci. Rep."},{"key":"84191_CR12","doi-asserted-by":"publisher","first-page":"102238","DOI":"10.1016\/j.coph.2022.102238","volume":"65","author":"JD Chandler","year":"2022","unstructured":"Chandler, J. D. & Esther, C. R. Metabolomics of airways disease in cystic fibrosis. Curr. Opin. Pharmacol. 65, 102238 (2022).","journal-title":"Curr. Opin. Pharmacol."},{"key":"84191_CR13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12890-018-0766-6","volume":"18","author":"V Terlizzi","year":"2018","unstructured":"Terlizzi, V. et al. Clinical expression of cystic fibrosis in a large cohort of Italian siblings. BMC Pulm Med. 18, 196 (2018).","journal-title":"BMC Pulm Med."},{"key":"84191_CR14","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1164\/rccm.201012-1995OC","volume":"183","author":"H Grasemann","year":"2011","unstructured":"Grasemann, H. et al. Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with cystic fibrosis. Am. J. Respir Crit. Care Med. 183, 1363\u20131368 (2011).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"84191_CR15","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.3390\/jcm9123802","volume":"9","author":"B Hanusch","year":"2020","unstructured":"Hanusch, B. et al. Local and systemic alterations of the L-arginine\/nitric oxide pathway in sputum, blood, and urine of pediatric cystic fibrosis patients and effects of antibiotic treatment. J. Clin. Med. 9, 3802 (2020).","journal-title":"J. Clin. Med."},{"key":"84191_CR16","doi-asserted-by":"publisher","first-page":"470","DOI":"10.2174\/1568026623666221213085917","volume":"23","author":"N Papageorgiou","year":"2023","unstructured":"Papageorgiou, N. et al. Asymmetric dimethylarginine as a biomarker in coronary artery disease. Curr. Top. Med. Chem. 23, 470\u2013480 (2023).","journal-title":"Curr. Top. Med. Chem."},{"key":"84191_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jpeds.2013.02.042","volume":"163","author":"H Grasemann","year":"2013","unstructured":"Grasemann, H. & Pencharz, P. B. Arginine metabolism in patients with cystic fibrosis. J. Pediatr. 163, 317\u2013319 (2013).","journal-title":"J. Pediatr."},{"key":"84191_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12933-023-01827-2","volume":"22","author":"I Forzano","year":"2023","unstructured":"Forzano, I. et al. L-Arginine in diabetes: clinical and preclinical evidence. Cardiovasc. Diabetol. 22, 89 (2023).","journal-title":"Cardiovasc. Diabetol."},{"key":"84191_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.clnesp.2023.06.005","volume":"57","author":"M Tosur","year":"2023","unstructured":"Tosur, M. et al. Plasma amino acid signatures define types of pediatric diabetes. Clin. Nutr. ESPEN 57, 21\u201328 (2023).","journal-title":"Clin. Nutr. ESPEN"},{"key":"84191_CR20","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1007\/s00394-020-02358-2","volume":"60","author":"W Bernhard","year":"2021","unstructured":"Bernhard, W. Choline in cystic fibrosis: relations to pancreas insufficiency, enterohepatic cycle, PEMT and intestinal microbiota. Eur. J. Nutr. 60, 1737\u20131739 (2021).","journal-title":"Eur. J. Nutr."},{"key":"84191_CR21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1086\/599360","volume":"200","author":"C Hoboth","year":"2009","unstructured":"Hoboth, C. et al. Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis. J. Infect. Dis. 200, 118\u2013130 (2009).","journal-title":"J. Infect. Dis."},{"key":"84191_CR22","doi-asserted-by":"crossref","first-page":"e00269","DOI":"10.1128\/mBio.00269-18","volume":"9","author":"R La Rosa","year":"2018","unstructured":"La Rosa, R., Johansen, H. K. & Molin, S. Convergent metabolic specialization through distinct evolutionary paths in Pseudomonas aeruginosa. mBio 9, e00269\u2013e00218 (2018).","journal-title":"mBio"},{"key":"84191_CR23","doi-asserted-by":"publisher","first-page":"e01894","DOI":"10.1128\/mBio.01894-18","volume":"9","author":"A Corral-Lugo","year":"2018","unstructured":"Corral-Lugo, A. et al. High-affinity chemotaxis to histamine mediated by the TlpQ chemoreceptor of the human pathogen Pseudomonas aeruginosa. mBio 9, e01894\u2013e01818 (2018).","journal-title":"mBio"},{"key":"84191_CR24","doi-asserted-by":"publisher","first-page":"6312","DOI":"10.3390\/ijms22126312","volume":"22","author":"T Krell","year":"2021","unstructured":"Krell, T. et al. Histamine: a bacterial signal molecule. Int. J. Mol. Sci. 22, 6312 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"84191_CR25","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1056\/NEJM198411223112116","volume":"311","author":"MH Sch\u00f6ni","year":"1984","unstructured":"Sch\u00f6ni, M. H., T\u00fcrler, K., K\u00e4ser, H. & Kraemer, R. Elevated dopa levels in cystic fibrosis. N. Engl. J. Med. 311, 1380 (1984).","journal-title":"N. Engl. J. Med."},{"key":"84191_CR26","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0140-6736(86)92616-4","volume":"2","author":"MA McPherson","year":"1986","unstructured":"McPherson, M. A., Dormer, R. L., Bradbury, N. A., Dodge, J. A. & Goodchild, M. C. Defective beta-adrenergic secretory responses in submandibular acinar cells from cystic fibrosis patients. Lancet 2, 1007\u20131008 (1986).","journal-title":"Lancet"},{"key":"84191_CR27","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.bbr.2015.01.042","volume":"286","author":"S Dhanda","year":"2015","unstructured":"Dhanda, S. & Sandhir, R. Role of dopaminergic and serotonergic neurotransmitters in behavioral alterations observed in rodent model of hepatic encephalopathy. Behav. Brain Res. 286, 222\u2013235 (2015).","journal-title":"Behav. Brain Res."},{"key":"84191_CR28","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s12967-021-03092-x","volume":"19","author":"B Roy","year":"2021","unstructured":"Roy, B. et al. Regional brain tissue changes in patients with cystic fibrosis. J. Transl. Med. 19, 419 (2021).","journal-title":"J. Transl. Med."},{"key":"84191_CR29","doi-asserted-by":"publisher","first-page":"11433","DOI":"10.1038\/s41598-017-11759-z","volume":"7","author":"H Chang","year":"2017","unstructured":"Chang, H. et al. Identification of key metabolic changes during liver fibrosis progression in rats using a urine and serum metabolomics approach. Sci. Rep. 7, 11433 (2017).","journal-title":"Sci. Rep."},{"key":"84191_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.dld.2021.06.034","volume":"54","author":"S Drzyma\u0142a-Czy\u017c","year":"2022","unstructured":"Drzyma\u0142a-Czy\u017c, S. et al. Serum bile acids in cystic fibrosis patients - glycodeoxycholic acid as a potential marker of liver disease. Dig. Liver Dis. 54, 111\u2013117 (2022).","journal-title":"Dig. Liver Dis."},{"key":"84191_CR31","doi-asserted-by":"publisher","first-page":"L1186","DOI":"10.1152\/ajplung.2000.278.6.L1186","volume":"278","author":"LJ Galietta","year":"2000","unstructured":"Galietta, L. J. et al. Modification of transepithelial ion transport in human cultured bronchial epithelial cells by interferon-\u03b3. Am. J. Physiol. Lung Cell. Mol. Physiol. 278, L1186\u2013L1194 (2000).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"84191_CR32","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1164\/rccm.201207-1346OC","volume":"187","author":"RG Iannitti","year":"2013","unstructured":"Iannitti, R. G. et al. Th17\/Treg imbalance in murine cystic fibrosis is linked to indoleamine 2,3-dioxygenase deficiency but corrected by kynurenines. Am. J. Respir Crit. Care Med. 187, 609\u2013620 (2013).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"84191_CR33","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1002\/ddr.21842","volume":"82","author":"P Prasher","year":"2021","unstructured":"Prasher, P. & Sharma, M. Medicinal chemistry of anthranilic acid derivatives: a mini review. Drug Dev. Res. 82, 945\u2013958 (2021).","journal-title":"Drug Dev. Res."},{"key":"84191_CR34","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jcf.2013.02.008","volume":"12","author":"A Kelly","year":"2013","unstructured":"Kelly, A. & Moran, A. Update on cystic fibrosis-related diabetes. J. Cyst. Fibros. 12, 318\u2013331 (2013).","journal-title":"J. Cyst. Fibros."},{"key":"84191_CR35","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/S1569-1993(11)60006-4","volume":"10","author":"D Debray","year":"2011","unstructured":"Debray, D., Kelly, D., Houwen, R., Strandvik, B. & Colombo, C. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. J. Cyst. Fibros. 10, S29\u2013S36 (2011).","journal-title":"J. Cyst. Fibros."},{"key":"84191_CR36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","volume":"17","author":"C Castellani","year":"2018","unstructured":"Castellani, C. et al. ECFS best practice guidelines: the 2018 revision. J. Cyst. Fibros. 17, 153\u2013178 (2018).","journal-title":"J. Cyst. Fibros."},{"key":"84191_CR37","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1515\/cclm-2017-0553","volume":"56","author":"A Bergougnoux","year":"2018","unstructured":"Bergougnoux, A. et al. Multicenter validation study for the certification of a CFTR gene scanning method using next generation sequencing technology. Clin. Chem. Lab. Med. 56, 1046\u20131053 (2018).","journal-title":"Clin. Chem. Lab. Med."},{"key":"84191_CR38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jmoldx.2011.09.001","volume":"14","author":"F Amato","year":"2012","unstructured":"Amato, F. et al. Extensive molecular analysis of patients bearing CFTR-related disorders. J. Mol. Diagn. 14, 81\u201389 (2012).","journal-title":"J. Mol. Diagn."},{"key":"84191_CR39","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1183\/09031936.00080312","volume":"40","author":"PH Quanjer","year":"2012","unstructured":"Quanjer, P. H. et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur. Respir J. 40, 1324\u20131343 (2012).","journal-title":"Eur. Respir J."},{"key":"84191_CR40","doi-asserted-by":"publisher","first-page":"e0164232","DOI":"10.1371\/journal.pone.0164232","volume":"11","author":"D Seidler","year":"2016","unstructured":"Seidler, D., Griffin, M., Nymon, A., Koeppen, K. & Ashare, A. Throat swabs and sputum culture as predictors of P. Aeruginosa or S. Aureus lung colonization in adult cystic fibrosis patients. PLoS ONE 11, e0164232 (2016).","journal-title":"PLoS One"},{"key":"84191_CR41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/MPG.0b013e31824f1516","volume":"55","author":"VD Morinville","year":"2021","unstructured":"Morinville, V. D. et al. Definitions of pediatric pancreatitis and survey of present clinical practices. J. Pediatr. Gastroenterol. Nutr. 55, 261\u2013265 (2021).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"84191_CR42","doi-asserted-by":"publisher","first-page":"9320","DOI":"10.1038\/s41598-018-27465-3","volume":"8","author":"AR Philp","year":"2018","unstructured":"Philp, A. R. et al. Kcnn4 is a modifier gene of intestinal cystic fibrosis preventing lethality in the Cftr-F508del mouse. Sci. Rep. 8, 9320 (2018).","journal-title":"Sci. Rep."},{"key":"84191_CR43","doi-asserted-by":"crossref","unstructured":"Costanzo, M., Caterino, M. & Ruoppolo, M. & Targeted metabolomics. In Metabolomics Perspectives, From Theory to Practical Application (ed. Troisi, J.) 219\u2013236 (Academic Press, 2022).","DOI":"10.1016\/B978-0-323-85062-9.00006-4"},{"key":"84191_CR44","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.3390\/biomedicines11102830","volume":"11","author":"I Campesi","year":"2023","unstructured":"Campesi, I. & Capobianco, G. Stratification of amniotic fluid cells and amniotic fluid by sex opens up new perspectives on fetal health. Biomedicines 11, 2830 (2023).","journal-title":"Biomedicines"},{"key":"84191_CR45","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13578-024-01245-1","volume":"14","author":"M Costanzo","year":"2024","unstructured":"Costanzo, M., Cevenini, A. & Kollipara, L. Methylmalonic acidemia triggers lysosomal-autophagy dysfunctions. Cell. Biosci. 14, 63 (2024).","journal-title":"Cell. Biosci."},{"key":"84191_CR46","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.dib.2022.107843","volume":"41","author":"M Costanzo","year":"2022","unstructured":"Costanzo, M. et al. Proteome data of neuroblastoma cells overexpressing neuroglobin. Data Brief 41, 107843 (2022).","journal-title":"Data Brief."},{"key":"84191_CR47","doi-asserted-by":"publisher","first-page":"109089","DOI":"10.1016\/j.dib.2023.109089","volume":"48","author":"M Costanzo","year":"2023","unstructured":"Costanzo, M. & Caterino, M. Targeted lipidomics data of COVID-19 patients. Data Brief 48, 109089 (2023).","journal-title":"Data Brief."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84191-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84191-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84191-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:02:36Z","timestamp":1735948956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84191-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["84191"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-84191-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"12 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by CF regional Centre of Campania (Ethics Committee number 77\/2021). The participants provided their written informed consent to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"479"}}